SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001008848-11-000067
Filing Date
2011-08-08
Accepted
2011-08-08 17:12:20
Documents
18
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 form10q063011.htm 10-Q 693282
2 rushlicense.htm EX-10.16 263001
3 ceneslicenseagmt.htm EX-10.22 547321
4 mayolicense.htm EX-10.24 1347099
5 rcemploymentagmtamended.htm EX-10.61 14659
6 lease2.htm EX-10.62 953801
7 medtronic.htm EX-10.63 708388
8 rushschedule171.jpg GRAPHIC 128658
9 CEOCERT exhibit311.htm EX-31.1 15033
10 CFOCERT exhibit312.htm EX-31.2 15709
11 CEOCERT exhibi321.htm EX-32.1 9580
12 CFOCERT exhibit322.htm EX-32.2 6270
  Complete submission text file 0001008848-11-000067.txt   8176714

Data Files

Seq Description Document Type Size
13 acor-20110630.xml EX-101.INS 528858
14 acor-20110630.xsd EX-101.SCH 29064
15 acor-20110630_cal.xml EX-101.CAL 54628
16 acor-20110630_def.xml EX-101.DEF 77341
17 acor-20110630_lab.xml EX-101.LAB 418222
18 acor-20110630_pre.xml EX-101.PRE 236603
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 111018018
SIC: 2836 Biological Products, (No Diagnostic Substances)